If you still have same management who signed this deal at board level then no you are not better off in my opinion.
entire medical/pharmaceutical industry works on royalty basis so so how on earth this guy's give out technology on one off fees and also dilute shareholders with issue of new shares ?
MX1 Price at posting:
16.0¢ Sentiment: None Disclosure: Not Held
